Insights

Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmBH are all now operations under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.
    October 23, 2012

    Beyond Scale-up, Part 4 of 4: Delivery Method Effect on Resource Demand

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    October 23, 2012

    Beyond Scale-up, Part 3 of 4: Success by Design

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    October 23, 2012

    Beyond Scale-Up, Part 2 of 4: Focus on Product Delivery

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    October 23, 2012

    Beyond Scale-Up: Managing Cost and Bedside Integrity of Cell Therapy Products in a Commercial Setting, Part 1 of 4

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    January 23, 2012

    Bench To Bedside: Cell Therapy Development and Commercialization Roadmap

    PCT's Dr. Sanjin Zvonic, drawing on more than 12 years of PCT's philosophy, experience and expertise, gives an overview of the key steps in the commercialization of cell ...

    Read More
    All Posts

    Subscribe to Our Email Distribution List
    © 2025 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint